Haemoglobinopathy

Details

Title

Haemoglobinopathy

Type

Stage One

Module code

HLS032

Requirement

Compulsory

Module objective

By the end of the training period trainees will, in respect of haemoglobinopathy, be able to:

• analyse, synthesise, evaluate and apply knowledge
• perform a range of technical and clinical skills and procedures
• demonstrate the attitudes and behaviours necessary for professional practice as a consultant clinical scientist dealing with the complexities, uncertainties and tensions of professional practice at this level.

Knowledge and understanding

1. Health and safety legislation and guidance
2. ACDP categorisation of biological agents
3. Laboratory safety and containment
4. Transport regulations

By the end of the training period the trainee will be able to demonstrate the ability to analyse, evaluate and synthesise relevant knowledge and its application to their professional practice in relation to the

• molecular basis of abnormal haemoglobins and thalassaemia syndromes
• natural history, epidemiology, presentation, genetics and diagnosis of thalassaemias, sickle cell disease and other haemoglobin abnormalities in adults and children
• phenotypic and genotypic laboratory methods used in the screening and diagnosis of abnormal haemoglobins.

Technical and clinical skills

By the end of the training period the trainee will be able to demonstrate a critical understanding of current relevant research, theory and knowledge and its application to the performance of the following technical procedures and laboratory skills:

• demonstrate competence in the laboratory diagnosis of haemoglobinopathy
• provide advice to hospital teams and general practitioners on antenatal diagnosis and screening of families potentially affected.

By the end of the training period the trainee will be able to apply knowledge of haemoglobinopathy to perform the clinical skills necessary to manage under supervision:

• to perform the clinical skills necessary to use clinical laboratory methods in the diagnosis and monitoring of haemoglobinopathy.